Tachykininergic

Tachykininergic refers to the actions or effects mediated by tachykinins, a family of neuropeptides that share a common C-terminal sequence and are involved in a variety of physiological processes. Tachykinins are known for their ability to induce rapid contractions in smooth muscles, hence the prefix "tachy-" meaning fast, and "-kinin" referring to their movement-inducing properties. The most studied tachykinins include substance P, neurokinin A, and neurokinin B, which interact with their respective G protein-coupled receptors (GPCRs), namely NK1, NK2, and NK3 receptors.

Function

Tachykininergic systems are involved in numerous physiological and pathological processes. They play a crucial role in the regulation of pain, inflammation, mood disorders, and blood pressure, as well as in the control of respiratory rate, gastrointestinal motility, and urinary function. Tachykinins act as neurotransmitters and neuromodulators in both the central and peripheral nervous systems, mediating their effects through the activation of specific receptors.

Pathophysiology

Alterations in tachykininergic signaling have been implicated in various diseases. For instance, elevated levels of substance P have been found in individuals suffering from depression, anxiety disorders, and chronic pain conditions, such as fibromyalgia and migraines. Furthermore, tachykininergic dysregulation is associated with asthma, irritable bowel syndrome (IBS), and rheumatoid arthritis, highlighting the potential of tachykinin receptor antagonists as therapeutic agents.

Therapeutic Implications

The discovery of tachykinin receptors and their specific roles has led to the development of receptor antagonists aimed at treating conditions related to tachykininergic dysfunction. For example, NK1 receptor antagonists have been explored for their potential in treating depression, anxiety, and chemotherapy-induced nausea and vomiting (CINV). Similarly, NK2 and NK3 receptor antagonists are under investigation for the treatment of asthma, irritable bowel syndrome, and certain reproductive system disorders.

Research Directions

Ongoing research aims to further elucidate the complex roles of tachykinins in health and disease, with a focus on identifying novel therapeutic targets within the tachykininergic system. The development of more selective and potent tachykinin receptor antagonists holds promise for the treatment of a wide range of conditions, offering hope for patients with diseases currently lacking effective therapies.

‎